Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Hormone Replacement Therapy After Risk-Reducing Surgery in Women at Increased Risk for Breast Cancer: The Patient Perspective
Glossary on
off
Printer Friendly Page Hormone Replacement Therapy After Risk-Reducing Surgery in Women at Increased Risk for Breast Cancer: The Patient Perspective

Hormone Replacement Therapy After Risk-Reducing Surgery in Women at Increased Risk for Breast Cancer: The Patient Perspective

Surveys, Registries, Interviews
Survey for women with a BRCA1, BRCA2, PALB2, RAD51C, RAD51D genetic mutation who have undergone risk-reducing bilateral salpingo-oophorectomy (removed both tubes and ovaries) to lower cancer risk

Study Contact Information:

Emily Stevens, [email protected], 289-689-3425
Erika Renkes, [email protected], 815-441-5003
Jill Stopfer, [email protected]

Hormone Replacement Therapy After Risk-Reducing Surgery in Women at Increased Risk for Breast Cancer: The Patient Perspective

About the Study

In this study, we aim to better understand patient perceptions about hormone replacement therapy () and identify factors informing decision making about for use in women who have a , , , or genetic mutation that increases breast and ovarian cancer risk. 

Individuals who have undergone risk-reducing surgery for ovarian cancer will be asked to complete a survey about their thoughts, experiences and understanding of the risks and benefits related to hormone replacement therapy.

What the Study Involves

Participants will be asked to complete one online survey estimated to take about 15-20 minutes. There is no follow-up after completing the survey. Participation is voluntary and participants can choose to opt out of the study at any point without consequence. Participants also have the option to skip questions without justification. Survey responses will be kept anonymous and identifying information will not be shared. Every reasonable effort will be made to keep data secure. Participants will not receive monetary compensation. However, it is hoped this research will lead to a better understanding of factors influencing women’s decisions about and all participation is appreciated.

Lead Researchers

Emily Stevens, Genetic Counseling Student
Sarah Lawrence College, Bronxville, NY

This Study is Open To:
  • 35-50 years old
  • no previous history of a breast cancer diagnosis
  • have undergone preventative surgical removal of both ovaries and (ie. risk-reducing salpingo-oophorectomy)
  • confirmed , , , or  genetic mutation
This Study is Not Open To:
  • A personal history of a breast cancer diagnosis